Rare diseases
Investigational molecules
Locations
A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
FranceA Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment
FranceLong-term Safety Study of Vusolimogene Oderparepvec, RP2, and RP3 in Patients with Melanoma, Liver Cancer, or Advanced Solid Tumors
FranceA Study of Mirvetuximab Soravtansine, Carboplatin, and Bevacizumab in Adults with Ovarian Cancer
Belgium
AustriaTesting Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease
AustriaA Study of Sacituzumab Tirumotecan, Pembrolizumab, and Bevacizumab for Patients with Metastatic Cervical Cancer That Has Spread or Returned
AustriaA Study of INCB123667 in Patients With Platinum-Resistant Ovarian Cancer That Has High Levels of Cyclin E1 Protein
BelgiumStudy Using Fluorescent Adalimumab and Risankizumab to See How These Drugs Work in Patients with Inflammatory Bowel Disease
The NetherlandsStudy of icotrokinra for adults with moderately to severely active Crohn's disease
BelgiumTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
BelgiumComparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
